Improvements in motor function and memory suggest human neurodevelopmental disorders may be amenable to treatment, even after onset of symptoms. According to a researcher, neurodevelopmental disorders ...

Feb. 11 -- TUESDAY, Feb. 10 (HealthDay News) -- Researchers may have found a new treatment for Rett syndrome, a rare inherited disease in girls that brings on autism-like symptoms along with heart and ...

New discoveries about the severe developmental disorder known as Rett syndrome could open the door to better treatments for the devastating, life-shortening condition. Scientists investigating the ...

Scientists investigating the severe developmental disorder known as Rett syndrome have discovered a series of crucial molecular changes that occur long before symptoms appear. The findings could be ...

Rett syndrome is a rare neurodegenerative disorder that almost exclusively affects girls. It is typically diagnosed in babies between six and 18 months of age, when the first symptoms begin to appear.

A new article published in the Cell Reports describes how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett syndrome in preclinical models. The study ...

Acadia Pharmaceuticals ACAD announced that it expects to receive a negative opinion from the European Medicines Agency’s (EMA ...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health Canada has granted marketing authorization of DAYBUE™ (trofinetide) for the treatment of Rett ...

Rett syndrome is a rare disorder linked to autism that affects brain development. Microglia, the resident immune cells of the central nervous system, have been implicated in the development of Rett ...

(RTTNews) - Acadia Pharmaceuticals Inc. (ACAD) announced the publication of clinical data from the open-label DAFFODIL study, which evaluated the long-term safety and efficacy of DAYBUE or trofinetide ...

(RTTNews) - Acadia Pharmaceuticals Inc. (ACAD) announced that the FDA has approved DAYBUE STIX for oral solution for the treatment of Rett syndrome in adult and pediatric patients two years of age and ...